Integra LifeSciences Holdings Corporation (IART) Securities Fraud Investigation - Levi & Korsinsky

By ACCESS Newswire

NEW YORK CITY, NY / ACCESS Newswire / October 2, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Integra LifeSciences Holdings Corporation ("Integra LifeSciences Holdings Corporation") (NASDAQ:IART) concerning potential violations of the federal securities laws.

Integra LifeSciences Holdings Corporation were falling nearly 20% midday on October 2, 2026, after the company lowered its full-year 2026 guidance and reported preliminary third-quarter revenue below analyst estimates. The company attributed the guidance cut and revenue shortfall to a July flood at its Cincinnati manufacturing facility, which damaged production assets and disrupted product supplies. The disruption is expected to further reduce fourth-quarter revenue by approximately $15 million to $20 million, with full manufacturing operations at the facility not expected to resume until the second quarter of 2027. During the previous earnings call on July 29, 2026, Chief Financial Officer Lea Daniels Knight indicated the company did "not expect the event to have a material impact on our revenue or EPS guidance for 2026."

If you suffered a loss on your Integra LifeSciences Holdings Corporation securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212)363-7500
Fax: (212)363-7171

SOURCE: Levi & Korsinsky, LLP



View the original press release on ACCESS Newswire

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.